North America Contraceptives Market Outlook 2021 | Revenue Models

23/ago/2017 12:24:32 Market Data Forecast Contatta l'autore

Questo comunicato è stato pubblicato più di 6 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The North America Contraceptives Market was worth $ 6.45 billion in 2016 and estimated to reach $ 8.80 billion by the end of 2021 with a growing potential of 6.40%.

 

Contraception methods can be permanent or temporary that are available for both men and women. Permanent methods include tubal occlusion or hysteroscopy and vasectomy. Temporary methods are of two types i.e., hormonal and non-hormonal. Hormonal methods include contraceptive transdermal patches, hormonal IUDs, oral contraceptive pills, vaginal implants, and vaginal rings. Non-hormonal methods include diaphragms, withdrawal methods, sponges, condoms, non-hormonal IUDs and cervical caps. Condoms, sponges, diaphragms, and cervical caps are also referred to as barrier contraception methods.

 

Full report at: http://www.marketdataforecast.com/market-reports/north-america-contraceptives-market-1229/

 

The North America market is mainly driven by increasing development of effective female contraceptive devices and drugs, technological advancements, increasing initiatives from government and NGO to promote contraceptives. Restraints that are hampering the growth of the market are the side effects associated with the use of contraceptive devices and drugs, rising prevalence of infertility.

 

Based on drug type the market is segmented into Contraceptive pills, Topical contraceptives, Contraceptive injectable, others (contraceptive gels, jellies and creams).

 

Based on medical devices the market is segmented into Male contraceptive devices (Condoms), Female contraceptive devices. Female contraceptive devices are further classified into female condoms, intrauterine devices (Hormonal IUD’s, Copper IUD’s), contraceptive sponges, contraceptive diaphragms, contraceptive patches, subdermal contraceptive implants and non-surgical permanent contraceptive devices.

 

Based on end users the market is segmented into Hospitals, Home care, Clinics and Ambulatory Surgical Centres. The North America market is analyzed under various regions namely U.S, Canada.

 

Request sample: http://www.marketdataforecast.com/market-reports/north-america-contraceptives-market-1229/request-sample

 

Some of the key players that are dominating the North America contraceptives market are Bayer HealthCare AG, Teva Pharmaceutical Industries Limited, Medisafe Distribution Inc, Pace Pharmaceuticals Inc., Medicines360, Church & Dwight, Co., Inc., Actavis, Inc., CooperSurgical, Inc., Merck & Co., Inc., Reckitt Benckiser plc, Mayer Laboratories, Inc., and Pfizer, Inc.

 

About Market Data Forecast:

The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com

 

Contact:

Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: +1-888-702-9626

Mobile: +91 998 555 0206

Mail: abhishek@marketdataforecast.com

Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/

 

View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl